Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias

Stroke

Volumn 43, Issue 3, 2012, Pages 808-814

  Gemmell, Elizabeth ^a   Bosomworth, Helen ^a   Allan, Louise ^a   Hall, Roslyn ^a   Khundakar, Ahmad ^a   Oakley, Arthur E ^a   Deramecourt, Vincent ^a   Polvikoski, Tuomo M ^a   O'Brien, John T ^a   Kalaria, Raj N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer disease; hippocampus; poststroke dementia; stroke; vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CELL DENSITY; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ELDERLY CARE; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIINFARCT DEMENTIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; STROKE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ATROPHY; CA1 REGION, HIPPOCAMPAL; CA2 REGION, HIPPOCAMPAL; CELL COUNT; COGNITION; DEMENTIA; ENTORHINAL CORTEX; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MALE; MEMORY; NEURODEGENERATIVE DISEASES; NEURONS; PROSPECTIVE STUDIES; PYRAMIDAL CELLS; STROKE; SURVIVORS; TISSUE BANKS;

EID: 84857644548     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.636498     Document Type: Article

References (44)

1. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 1996;46:154-159.
2. Melkas S, Oksala NK, Jokinen H, Pohjasvaara T, Vataja R, Oksala A, et al. Poststroke dementia predicts poor survival in long-term follow-up: influence of prestroke cognitive decline and previous stroke. J Neurol Neurosurg Psychiatry. 2009;80:865-870.
3. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006-1018.
4. Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging. 2007;28:1664-1669.
5. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6:67-77.
6. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology. 1999;52:1153-1158.
7. Bastos-Leite AJ, van der Flier WM, van Straaten EC, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke. 2007;38:3182-3185.
8. Scher AI, Xu Y, Korf ES, Hartley SW, Witter MP, Scheltens P, et al. Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS. J Neurol Neurosurg Psychiatry. 2011;82:373-376.
9. Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry. 2002;72:747-751.
10. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology. 2000;54:1304-1309.
11. O'Sullivan M, Ngo E, Viswanathan A, Jouvent E, Gschwendtner A, Saemann PG, et al. Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging. 2009;30:890-897.
12. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol. 2001;58:1395-1402.
13. Kril JJ, Hodges J, Halliday G. Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease. Neurosci Lett. 2004;361:9-12.
14. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 1991;40:599-636.
15. Wu W, Brickman AM, Luchsinger J, Ferrazzano P, Pichiule P, Yoshita M, et al. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol. 2008;64:698-706.
16. Apostolova LG, Green AE, Babakchanian S, Hwang KS, Chou Y-Y, Toga AW, et al. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer disease. Alzheimer Dis Assoc Disord. Epub ahead of print March 25, 2011. DOI:10.1097/WAD.0b013e3182163b62.
17. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 1994;344:769-772.
18. Pakkenberg B, Pelvig D, Marner L, Bundgaard MJ, Gundersen HJ, Nyengaard JR, et al. Aging and the human neocortex. Exp Gerontol. 2003;38:95-99.
19. Rossler M, Zarski R, Bohl J, Ohm TG. Stage-dependent and sectorspecific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol. 2002;103:363-369.
20. Korbo L, Amrein I, Lipp HP, Wolfer D, Regeur L, Oster S, et al. No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients. Acta Neurol Scand. 2004;109:132-139.
21. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol. 2005;57:896-903.
22. Terry RD, De Teresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol. 1987;21:530-539.
23. Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HB. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol Aging. 1994;15:369-371; discussion 379-380.
24. Morrison JH, Hof PR. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res. 2002;136:467-486.
25. Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci. 2010;21:187-221.
26. Freeman SH, Kandel R, Cruz L, Rozkalne A, Newell K, Frosch MP, et al. Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease. J Neuropathol Exp Neurol. 2008;67:1205-1212.
27. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke. 2003;34:2440-2444.
28. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci. 2004;226:75-80.
29. Allan LM, Rowan EN, Firbank MJ, Thomas AT, Parry S, Polvikoski TM, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain. In press.
30. Perry RH, Oakley AE. Newcastle brain map. In Roberts G, Leigh P, Weinberger D, eds. Neuropsychiatric Disorders. 1st Ed. London, Wolfe publishing; 1993:1-10.
31. Insausti R, Juottonen K, Soininen H, Insausti AM, Partanen K, Vainio P, et al. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am J Neuroradiol. 1998;19:659-671.
32. Canto CB, Wouterlood FG, Witter MP. What does the anatomical organization of the entorhinal cortex tell us? Neural Plast. 2008:381243, 2008.
33. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc. 1984;134:127-136.
34. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, Stockmeier CA, Krishnan KR. Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry. 2005;58:297-306.
35. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987;147:229-263.
36. Gundersen HJ. The nucleator. J Microsc. 1988;151:3-21.
37. Schonheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging. 2004;25:697-711.
38. Chevaleyre V, Siegelbaum SA. Strong CA2 pyramidal neuron synapses define a powerful disynaptic cortico-hippocampal loop. Neuron. 2010;66:560-572.
39. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, et al. Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging. 2010;31:1077-1088.
40. Harrison PJ, Eastwood SL. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 2001;11:508-519.
41. van de Nes JA, Nafe R, Schlote W. Non-tau based neuronal degeneration in Alzheimer's disease-an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. Brain Res. 2008;1213:152-165.
42. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, et al. The new stereological tools: dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988;96:857-881.
43. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, et al. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology. 2011;76:1478-1484.
44. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-817.